Table of Content

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines


2. EXECUTIVE SUMMARY


3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of At-Home Blood Collection and Micro Sampling Devices
3.3. Applications of Blood Sampling and Testing
3.3.1. Complete Blood Count
3.3.2. Basic Metabolic Panel
3.3.3. Lipoprotein Panel
3.4. Types of Blood Sampling
3.4.1. Dried Blood Sampling
3.4.2. Wet Blood Sampling

3.5. Benefits of At-Home Blood Collection
3.6. Methods Used for At-Home Blood Collection
3.6.1. Fingerstick Method
3.6.2. Press Button Method
3.6.3. Heel-stick Method
3.7. Types of At-Home Blood Collection and Micro Sampling Devices
3.7.1. Dried Blood Spot Collection Kits
3.7.2. Microtainer Tubes

3.8. Future Perspectives

4. MARKET OVERVIEW
4.1. Chapter Overview
4.2. At-Home Blood Collection and Micro Sampling Devices: Overall Market Landscape
4.2.1. Analysis by Device Class
4.2.2. Analysis by Current Status of Development
4.2.3. Analysis by Regulatory Approvals / Certifications Received
4.2.4. Analysis by Type of Technology
4.2.5. Analysis by Device Usage
4.2.6 Analysis by Type of Sample
4.2.7. Analysis by Blood Sample State
4.2.8. Analysis by Volume of Sample Collected
4.2.9. Analysis by Puncture Site
4.2.10. Analysis by Method of Sample Collection
4.2.11. Analysis by Storage Temperature
4.2.12. Analysis by Application Area
4.3. At-Home Blood Collection and Micro Sampling Devices: List of Developers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Geography
4.3.4. Analysis by Year of Establishment, Company Size and Location of Headquarters
4.4. Most Active Players: Analysis by Number of Products

5. PRODUCT COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Input Parameters
5.3. Methodology
5.3.1. Product Competitiveness Analysis: North America
5.3.2. Product Competitiveness Analysis: Europe
5.3.3. Product Competitiveness Analysis: Asia-Pacific

6. COMPANY PROFILES
6.1. Chapter Overview
6.2. EUROIMMUN
6.2.1. Company Overview
6.2.2. Product Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Everlywell
6.3.1. Company Overview
6.3.2. Product Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. Labcorp
6.4.1. Company Overview
6.4.2. Product Portfolio
6.4.3. Recent Developments and Future Outlook
6.5. Labonovum
6.5.1. Company Overview
6.5.2. Product Portfolio
6.5.3. Recent Developments and Future Outlook
6.6. Lameditech
6.6.1. Company Overview
6.6.2. Product Portfolio
6.6.3. Recent Developments and Future Outlook
6.7. Quest Diagnostics
6.7.1. Company Overview
6.7.2. Product Portfolio
6.7.3. Recent Developments and Future Outlook
6.8. Spot On Sciences
6.8.1. Company Overview
6.8.2. Product Portfolio
6.8.3. Recent Developments and Future Outlook
6.9. Tasso
6.9.1. Company Overview
6.9.2. Product Portfolio
6.9.3. Recent Developments and Future Outlook
6.10. Weavr Health
6.10.1. Company Overview
6.10.2. Product Portfolio
6.10.3. Recent Developments and Future Outlook
6.11. YourBio Health
6.11.1. Company Overview
6.11.2. Product Portfolio
6.11.3. Recent Developments and Future Outlook

7. PATENT ANALYSIS
7.1. Chapter Overview
7.2. At-Home Blood Collection and Micro Sampling Devices: Patent Analysis
7.2.1. Scope and Methodology
7.2.2. Analysis by Publication Year
7.2.3. Analysis by Publication Year and Type of Patent
7.2.4. Analysis by Geography
7.2.5. Analysis by CPC Symbols
7.2.6. Analysis by Emerging Focus Area
7.2.7. Most Active Players: Analysis by Number of Patents
7.2.8. Patent Benchmarking Analysis
7.2.9. Patent Valuation Analysis
7.2.10. Overall Intellectual Property Portfolio: Analysis by Type of Organization

8. PARTNERSHIPS
8.1. Chapter Overview
8.2. Partnership Models
8.3. At-Home Blood Collection and Micro Sampling Devices: List of Partnerships
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year and Type of Partnership
8.3.4. Analysis by Focus Area
8.3.5. Analysis by Year of Partnership and Focus Area
8.3.6. Analysis by Type of Partnership and Focus Area
8.3.7. Analysis by Therapeutic Area
8.3.8. Analysis by Region
8.3.8.1. Continent-wise Distribution
8.3.8.2. Intercontinental and Intracontinental Distribution
8.3.8.3. Country-wise Distribution
8.3.9. Most Active Players: Analysis by Number of Partnerships

9. FUNDING AND INVESTMENT ANALYSIS
9.1. Chapter Overview
9.2. Types of Funding
9.3. At-Home Blood Collection and Micro Sampling Devices: Funding and Investment Analysis
9.3.1. Analysis of Number of Funding Instances by Year
9.3.2. Analysis by Amount Invested
9.3.3. Analysis by Type of Funding
9.3.4. Analysis by Year and Type of Funding
9.3.5. Analysis of Amount Invested by Geography
9.3.6. Most Active Players: Analysis by Number of Funding Instances and Amount Invested
9.3.7. Key Investors: Analysis by Number of Funding Instances
9.3.8. Analysis by Purpose of Investment
9.3.9. Analysis by Application Area
9.4. Concluding Remarks

10. COST SAVING ANALYSIS
10.1. Chapter Overview
10.2. Key Assumptions
10.3. Methodology
10.4. Overall Cost Saving Potential of At-Home Blood Collection and Micro Sampling Devices
10.5. Concluding Remarks

11. MARKET FORECAST
11.1. Chapter Overview
11.2. Forecast Methodology and Assumptions
11.3. Global At-Home Blood Collection and Micro Sampling Devices Market, 2021-2035
11.3.1. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2035: Analysis by Blood Sample State
11.3.1.1. At-Home Blood Collection and Micro Sampling Devices Market for Dried Blood Samples, 2021-2035
11.3.1.2. At-Home Blood Collection and Micro Sampling Devices Market for Liquid Blood Samples, 2021-2035
11.3.2. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2035: Analysis by Method of Sample Collection
11.3.2.1. At-Home Blood Collection and Micro Sampling Devices Market for Fingerstick Method of Sample Collection, 2021-2035
11.3.2.2. At-Home Blood Collection and Micro Sampling Devices Market for Push-Button Method of Sample Collection, 2021-2035
11.3.3. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2035: Analysis by Device Usage
11.3.3.1. At-Home Blood Collection and Micro Sampling Devices Market for Single-use Devices, 2021-2035
11.3.3.2. At-Home Blood Collection and Micro Sampling Devices Market for Reusable Devices, 2021-2035
11.3.4. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2035: Analysis by Area of Application
11.3.4.1. At-Home Blood Collection and Micro Sampling Device Market for Diagnostics, 2021-2035
11.3.4.2. At-Home Blood Collection and Micro Sampling Device Market for Research, 2021-2035
11.3.4.3. At-Home Blood Collection and Micro Sampling Device Market for Therapeutics, 2021-2035
11.3.4.4. At-Home Blood Collection and Micro Sampling Device Market for Other Areas of Application, 2021-2035
11.3.5. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2035: Analysis by Region
11.3.5.1. At-Home Blood Collection and Micro Sampling Devices Market in North America, 2021-2035
11.3.5.2. At-Home Blood Collection and Micro Sampling Devices Market in Europe, 2021-2035
11.3.5.3. At-Home Blood Collection and Micro Sampling Devices Market in Asia-Pacific, 2021-2035
11.3.5.4. At-Home Blood Collection and Micro Sampling Devices Market in Latin America, 2021-2035
11.3.5.5. At-Home Blood Collection and Micro Sampling Devices Market in MENA, 2021-2035
12. CONCLUSION
13. EXECUTIVE INSIGHTS
13.1. Chapter Overview
13.2. Interview Transcript: Radhika Pawa, Business Development Manager, Lipomic Healthcare
14. APPENDIX I: TABULATED DATA
15. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS